omniture

China Holdings Inc. Announces Appointment of Chairmen of Advisory Board and IR Partners

2007-07-09 11:42 726

LAS VEGAS, July 8 /Xinhua-PRNewswire/ -- China Holdings, Inc. (OTC Bulletin Board: CHHL) engages in multiple China-focused business activities including pharmaceutical, real estate, utilities, energy and finance. Today, the Company announced the appointment of the Company's Chairmen of the Advisory Board and IR Programs to assist in achieving its Renewable Energy, Energy Strategy & Plan in China, and worldwide.

The Company has appointed Mr. Kamalabadi as The Chairman of Advisory Board, Energy Section. Mr. Kamalabadi F. is the President & Chairman of the Board, Future Trend, a China specialist US Corporation engaged in investment and trade consulting, oil and gas and energy and government lobbying. He is recognized as a leader in grassroots government, enterprise, and media relations and networking throughout China. Mr. Kamalabadi has also served in various capacities for business development or as Senior Advisor to a number of national oil systems in such countries as Oman, Kuwait, and China. He has successfully concluded various oil and petrochemical trading transactions and projects such as securing oil exploration rights or concessions for specific clients.

Currently, Mr. Ronald Shon is the Chairman of the Advisory Board. Mr. Shon is the President of The Shon Group of Companies, a group of privately held real estate investment, such as The Cathedral Office Building (AAA+) in downtown Vancouver and development companies. Mr. Shon is also the President of China Education Resources Inc., and a director of the Spectra Group of Great Restaurants Inc. Mr. Shon holds a B.A. from Stanford University and an M.B.A. from the Wharton School of Business, University of Pennsylvania.

The Company has also re-retained Investor Relations International (IRI) to lead an expanded shareholder communication program. As investor relations counsel for China Holdings, Los Angeles-based IRI will raise investor awareness of the company's performance through a multi-channel campaign. IRI will employ print and electronic media as well as direct communication with money managers and current or prospective shareholders. The IRI program, focused on communicating China Holdings' expansion strategy across China, seeks both to broaden the Company's shareholder base and to solidify the long-term loyalty of current shareholders. The one crucial element we have lacked up to this point is a strong investor-relations program to raise our profile on Wall Street and give us better access to the capital markets should we require it. Our retention of IRI fills that gap, and we expect to benefit from much greater visibility and liquidity from here on.

The Company's objective is to achieve long-term capital appreciation through investment in companies and other entities with significant assets, investments, production activities, trading or other business interests in China, and/or worldwide, and/or which derive a significant part of their revenue from China, and/or worldwide.

About China Holdings, Inc.

China Holdings, Inc. is a development stage company with the goal of becoming a diversified global asset holding company. The Company and its subsidiaries engage in multiple China-focused business activities including pharmaceutical, real estate, utilities, energy and finance. Its objective is to achieve long-term capital appreciation through investment in companies and other entities with significant assets, investments, production activities, trading or other business interests in China, and/or worldwide, and/or which derive a significant part of their revenue from China, and/or worldwide.

The Company has two wholly-owned subsidiaries: (i) China Power, Inc., and (ii) China Health Holdings, Inc.

About China Power, Inc.

China Power Inc., a wholly owned subsidiary of China Holdings, Inc, is a development stage company with the goal of becoming a global leading energy holding corporation, that focuses on the Merger & Acquisition, investment, Research & Development, construction and operation of energy, and renewable energy, and environment protection projects in China and worldwide.

About China Health Holdings, Inc.

China Health Holdings, Inc. a wholly owned subsidiary of China Holdings, Inc., is a development stage company with the goal of becoming a leading developer, manufacturer, marketer and distributor of pharmaceutical drugs and dietary supplements in China and worldwide. The Company's main objective is to partner with CHINA -- SFDA approved drug producers, GMP certified manufacturing facilities, research and development centers and universities in China. The Company's goals for 2007-2009 include the profitable penetration of the Chinese pharmaceutical industry by merger and acquisition (M&A) leading pharmaceutical companies in the China. The Company's strategy is to leverage synergies, integrate drug pipelines and distribution channels, and management expertise between pending pharmaceutical acquisitions.

The Company's website: http://www.chinahealthholding.com and http://www.chinaholdings.org will be updated on July 15, 2007 approximately.

About Investor Relations International

Investor Relations International (IRI), based in Los Angeles, is a leading investor relations firm serving a worldwide client base. The principals of IRI have developed award-winning investor relations programs for a number of NYSE and Nasdaq-listed companies such as Insmed Inc., Internet Capital Group, LJ International, Starwood Hotels & Resorts Worldwide, ValueVision International and others, and have assisted dozens of public companies ranging from emerging small-cap companies to multinational corporations with market capitalizations in excess of $15 billion. IRI designs and implements customized investor relations programs to meet each client's unique needs. It enjoys one of the highest client retention rates in the industry.

For worldwide investor and media inquiries, please contact:

China Holdings, Inc., Las Vegas

Julianna Lu

Chief Executive Officer

Tel/Fax: +86-10-6586-4790 (China)

+1-604-608-6788 (North America)

Mobile: +86-1370-133-1287 (China)

Email: info@chinahealthholding.com

Investor Relations International (Los Angeles)

Haris Tajyar, Managing Partner

Tel: +1-818-382-9702

Email: htajyar@irintl.com

Safe Harbor Statement: To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof.

Source: China Holdings, Inc.
Related Stocks:
OTC:CHHL
collection